Larysa Nogaieva

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Cherkasy State Technological University(Current)

Larysa Nogaieva is an author at Cherkasy State Technological University specializing in pharmacology, pharmacotherapy, and primary refractory lymphoma.

Publications per year

2022–2022

Publications

A phase III, randomised, double‐blind, multi‐national clinical trial comparing SB12 (proposed eculizumab biosimilar) and reference eculizumab in patients with paroxysmal nocturnal haemoglobinuria

Jun Ho Jang, Roberta Demichelis‐Gómez, Horia Bumbea et al. · eJHaem · 2022 · 17 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Lisaftoclax (APG-2575) Safety and Activity As Monotherapy or Combined with Acalabrutinib or Rituximab in Patients (pts) with Treatment-Naïve, Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (R/R CLL/SLL): Initial Data from a Phase 2 Global Study

Matthew S. Davids, Asher Chanan‐Khan, Boyd Mudenda et al. · Blood · 2022 · 16 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

1–2 of 2